Works matching IS 15228517 AND DT 2018 AND VI 20 AND IP 2

Results: 20

Corrigendum.

Published in:: Neuro-Oncology, 2018, v. 20, n. 2, p. 293, doi. 10.1093/neuonc/nox226
Publication type:: Article

Society News.

Published in:: Neuro-Oncology, 2018, v. 20, n. 2, p. 292, doi. 10.1093/neuonc/nox246
Publication type:: Article

Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 289, doi. 10.1093/neuonc/nox217

By:

Prust, Morgan L.;
Jafari-Khouzani, Kourosh;
Kalpathy-Cramer, Jayashree;
Polaskova, Pavlina;
Batchelor, Tracy T.;
Gerstner, Elizabeth R.;
Dietrich, Jorg

Publication type:

Article

Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 279, doi. 10.1093/neuonc/nox153

By:

Suchorska, Bogdana;
Giese, Armin;
Biczok, Annamaria;
Unterrainer, Marcus;
Weller, Michael;
Drexler, Mark;
Bartenstein, Peter;
Schüller, Ulrich;
Tonn, Jörg-Christian;
Albert, Nathalie L.

Publication type:

Article

Brain volume reduction after whole-brain radiotherapy: quantification and prognostic relevance.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 268, doi. 10.1093/neuonc/nox150

By:

Hoffmann, Christian;
Distel, Luitpold;
Knippen, Stefan;
Gryc, Thomas;
Schmidt, Manuel Alexander;
Fietkau, Rainer;
Putz, Florian

Publication type:

Article

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 259, doi. 10.1093/neuonc/nox151

By:

Cloughesy, Timothy F.;
Drappatz, Jan;
de Groot, John;
Prados, Michael D.;
Reardon, David A.;
Schiff, David;
Chamberlain, Marc;
Mikkelsen, Tom;
Desjardins, Annick;
Ping, Jerry;
Holland, Jaymes;
Weitzman, Ron;
Wen, Patrick Y.

Publication type:

Article

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 249, doi. 10.1093/neuonc/nox154

By:

Wen, Patrick Y.;
Drappatz, Jan;
de Groot, John;
Prados, Michael D.;
Reardon, David A.;
Schiff, David;
Chamberlain, Marc;
Mikkelsen, Tom;
Desjardins, Annick;
Holland, Jaymes;
Jerry Ping;
Weitzman, Ron;
Cloughesy, Timothy F.

Publication type:

Article

Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 236, doi. 10.1093/neuonc/nox142

By:

Garnier, Delphine;
Meehan, Brian;
Kislinger, Thomas;
Daniel, Paul;
Sinha, Ankit;
Abdulkarim, Bassam;
Ichiro Nakano;
Rak, Janusz

Publication type:

Article

Glioblastoma in elderly patients: solid conclusions built on shifting sand?

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 175, doi. 10.1093/neuonc/nox133

By:

Wick, Antje;
Kessler, Tobias;
Elia, Andrew E. H.;
Winkler, Frank;
Batchelor, Tracy T.;
Platten, Michael;
Wick, Wolfgang

Publication type:

Article

microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 215, doi. 10.1093/neuonc/nox138

By:

Bhere, Deepak;
Kaoru Tamura;
Hiroaki Wakimoto;
Sung Hugh Choi;
Purow, Benjamin;
Debatisse, Jeremy;
Shah, Khalid

Publication type:

Article

Selective BCL-X<sub>L</sub> inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cells.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 203, doi. 10.1093/neuonc/nox134

By:

Levesley, Jane;
Steele, Lynette;
Brüning-Richardson, Anke;
Davison, Adam;
Jia Zhou;
Chunyong Ding;
Lawler, Sean;
Short, Susan C.

Publication type:

Article

Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 192, doi. 10.1093/neuonc/nox119

By:

Olmez, Inan;
Love, Shawn;
Aizhen Xiao;
Manigat, Laryssa;
Randolph, Peyton;
McKenna, Brian D.;
Neal, Brian P.;
Boroda, Salome;
Ming Li;
Brenneman, Breanna;
Abounader, Roger;
Floyd, Desiree;
Jeongwu Lee;
Ichiro Nakano;
Godlewski, Jakub;
Bronisz, Agnieszka;
Sulman, Erik P.;
Mayo, Marty;
Gioeli, Daniel;
Weber, Michael

Publication type:

Article

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 184, doi. 10.1093/neuonc/nox175

By:

Sarkaria, Jann N.;
Hu, Leland S.;
Parney, Ian F.;
Pafundi, Deanna H.;
Brinkmann, Debra H.;
Laack, Nadia N.;
Giannini, Caterina;
Burns, Terence C.;
Kizilbash, Sani H.;
Laramy, Janice K.;
Swanson, Kristin R.;
Kaufmann, Timothy J.;
Brown, Paul D.;
Agar, Nathalie Y. R.;
Galanis, Evanthia;
Buckner, Jan C.;
Elmquist, William F.

Publication type:

Article

Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 225, doi. 10.1093/neuonc/nox139

By:

Speranza, Maria-Carmela;
Passaro, Carmela;
Ricklefs, Franz;
Kasai, Kazue;
Klein, Sarah R.;
Hiroshi Nakashima;
Kaufmann, Johanna K.;
Ahmed, Abdul-Kareem;
Nowicki, Michal O.;
Obi, Prisca;
Bronisz, Agnieszka;
Aguilar-Cordova, Estuardo;
Aguilar, Laura K.;
Guzik, Brian W.;
Breakefield, Xandra;
Weissleder, Ralph;
Freeman, Gordon J.;
Reardon, David A.;
Wen, Patrick Y.;
Chiocca, E. Antonio

Publication type:

Article

Pediatric low-grade gliomas: next biologically driven steps.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 160, doi. 10.1093/neuonc/nox141

By:

Jones, David T. W.;
Kieran, Mark W.;
Bouffet, Eric;
Alexandrescu, Sanda;
Bandopadhayay, Pratiti;
Bornhorst, Miriam;
Ellison, David;
Fangusaro, Jason;
Fisher, Michael J.;
Foreman, Nicholas;
Fouladi, Maryam;
Hargrave, Darren;
Hawkins, Cynthia;
Jabado, Nada;
Massimino, Maura;
Mueller, Sabine;
Perilongo, Giorgio;
van Meeteren, Antoinette Y. N. Schouten;
Tabori, Uri;
Warren, Katherine

Publication type:

Article

Meeting Update--Society for Neuro-Oncology 2017 Annual Meeting.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 156, doi. 10.1093/neuonc/nox239

By:

Strowd, Roy E.;
Kim, Albert H.;
Wen, Patrick Y.

Publication type:

Article

Highlights from the Literature.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 153, doi. 10.1093/neuonc/nox247

By:

Bhat, Krishna;
Gerstner, Elizabeth;
Hegi, Monika;
Viapiano, Mariano

Publication type:

Article

Ritanserin, a novel agent targeting the mesenchymal subtype of glioblastomas.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 151, doi. 10.1093/neuonc/nox240

By:

Audia, Alessandra;
Bhat, Krishna P.

Publication type:

Article

Pediatric low-grade gliomas: a brave new world.

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 149, doi. 10.1093/neuonc/nox221

By:

Rubin, Joshua B.;
Finlay, Jonathan L.

Publication type:

Article

The siren song of bevacizumab: swan song or clarion call?

Published in:

Neuro-Oncology, 2018, v. 20, n. 2, p. 147, doi. 10.1093/neuonc/nox244

By:

Schiff, David;
Wen, Patrick Y.

Publication type:

Article